A preclinical-stage women’s health biotech focused uniquely on ovarian biology.
New York, NY
Joined December 2009
- Tweets1.7K
- Following707
- Followers1.3K
- Likes1.8K
Pinned Tweet
@DDNewsOnline's @NatOrtolano interviews our CEO Dr. @pirayebeim in headlining article "Is Anti-Müllerian Hormone the New Estrogen?" bit.ly/34jKs5z #WomensHealth #biotech
A comprehensive look at discussions on #menopause by @FastCompany's @ainsleyoc featuring @celmatix "One of the biggest lies in healthcare today is that menopause is a natural phenomenon"...@pirayebeim says. In her eyes, it’s a “public health crisis.”
bit.ly/3p9CLsC
We regularly discuss the complicated health toll of #menopause on women, now a new study from @MayoClinic uncovers a sizable financial toll as well. Findings reveal menopause is estimated to cost $1.8 billion in the US annually #endmenopause nytimes.com/2023/04/28/well/…
Wonderful to be included in @NewYorker's “The Future of Fertility” piece this month w/ @celmatix Founder @pirayebeim's perspective on what the future of #fertility could truly hold, & the critical work needed to address women's reproductive longevity.
newyorker.com/magazine/2023/…
Our founder, Dr. @pirayebeim shares why Celmatix is focused on #ovarian health, extending ovarian function, and importantly ending #menopause.
#womenshealth
SHE Media Co-lab Speaker + Founder of @Celmatix Dr. @PirayeBeim calls for an end to #menopause. See what else she had to say about #ovarianhealth alongside Dr @JShepherd_MD + SHE Media VP, Video
@reshingbull at our Future of Health event at @SXSW®.
📷: bit.ly/3KXUjAs
Celmatix retweeted
🚀 Biotech company @Celmatix launches novel PCOS drug program targeting melatonin receptors
More on this: femtechinsider.com/celmatix-…
#biotech #pcos #ovarianbiology
Celmatix's #melatonin drug program addresses a critical gap in the market for effective treatments for a range of women’s health indications, starting w/ #PCOS, w/ the potential to expand into the treatment of #endometriosis and #menopausal symptoms. businesswire.com/news/home/2…
A behind-the-scenes look at today's interview w/ @OprahDaily as @pirayebeim shares more on the role of the #ovary & why @celmatix is working to end #menopause. We're excited for the interview to come out next week along w/ other announcements from our team. Stay tuned!
Proud to be a part of the largest study on #endometriosis #genetics conducted to date.
‼️ OUT TODAY @NatureGenet
📰 The genetic basis of #endometriosis and comorbidity with other pain and inflammatory conditions
🧑🏽🤝🧑🏼 @Nilosh @KrinaZondervan @Ox_wrh
and colleagues
⬇️
go.nature.com/3LmNxVC
Celmatix & collaborators announced findings today in @NatureGenet on the #genetic basis of #endometriosis. Research reveals a shared #genetic basis for endometriosis and other types of pain seemingly unrelated to endometriosis. Read more here:businesswire.com/news/home/2…
The #changemakers issue from @iamwellandgood features @celmatix founder and CEO, Dr. Piraye Yurttas Beim as a founder driving real progress in #womenshealth. We're proud to be included in their series on the future of wellness.
wellandgood.com/medical-gasl…
Excited to join the speakers @SheKnowsMedia #SXSW w/@katiecouric, @CTurlington & others. @pirayebeim will speak on #menopause & longevity & how @Celmatix is working to extend ovarian function w/ groundbreaking #therapeutics.
shemedia.com/sxsw-2023
Excited to announce the opening of our Cambridge/Boston office in Kendall Square at @CICcambridge – at Cambridge, MA
Dr. @pirayebeim speaking today at @LongwoodFund's #longwoodhealthcareleaders event alongside #biotech execs from @Organon, @unicycive, @ConcertPharma, @OcuTerra, & others bit.ly/3ygwOwE @shalabhguptamd @DrGFiore
Celmatix retweeted
🧬 @celmatix, @bayer & @Evotec just hit another milestone in their quest to develop a first-in-class drug for #PCOS
💬"Novel PCOS drug target progresses into hit-identification."
Full story: femtechinsider.com/celmatix-…
#womenshealth #biotech
Validation of our 1st #pcos #drugdiscovery program by our partners at @Evotec and @Bayer #womenshealth
bwnews.pr/3fBozAE
Celmatix retweeted
Many modern-day #innovations are born in the #lab.
On 09/08 @ 1 PM ET, join @AtomwiseInc's Abraham Heifets, @CornellEng's Andrea Ippolito, @StrandTx's Jacob Becraft, and @celmatix's Piraye Beim to hear their journeys from #science to #startups: ecornell.cornell.edu/keynote…
A new study from @BristolUni & @IARCWHO reveals key differences between men's & women's risk of cancer due to obesity.."reinforcing how important it is to include a wide and diverse range of people in research studies"
#womenshealth #oncology
bit.ly/2J8dYAE
We're excited for tomorrow's @CoyaPartners "What Women Want"! @pirayebeim will be joining @FemTech_Focus @AvaWomen @sanogenetics @WILD_AI_Coach @Helene_wild_ai to disucss #AI & #BigData's impact on #womenshealth. Purchase a discounted ticket at: coyapartners.com/what-women-…
It was wonderful to virtually gather with our PReM partners for this evening's network symposium. Representing some of the country’s most respected #reproductivehealth researchers and providers, our partners are committed to innovation through better research.
Honored to be collaborating w/ @UCSF_ObGynRS, @UconnFertility, @viosfertility, @StanfordMed, @RMAofNY, @YaleSPH, @RMAMichigan @Fertility_RMACT, @columbiamed @SGFfertility, Fertility Specialists Medical Group, & RMA Philadelphia on progressing research discoveries in #womenshealth
